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Vaccination against hepatitis B virus in renal transplant recipients: A
comparative study between patients (pts.) treated with azathioprin/
steroids and cyclosporine A (CsA) monotherapy. Huser B, Frdsner G,
Landmann J, Thiel G. Aus dem Department für Innere Medizin und
Chirurgie, Kantonsspital Base!, Switzerland, und vain Max Pettenkofer
Institut Universitüat München, Germany. We investigated the response
to hepatitis vaccination in 24 renal transplant recipients. All pts. had
negative titers for hepatitis B antigen and antibody, and there was no
evidence for liver disease. For vaccination, the following schedule was
applied: on day 0, 3 ml of hepatitis B vaccine (Pasteur) was given
subcutaneously (s.c.) and another 1 ml on days 30, 60, 180, and 360. The
immune response was estimated by a semiquantitative radioimmu-
noassay and a quantitative determination of antibodies against hepatitis
B virus was performed on days 0, 30, 60, 120, 180, and 400. In the group
of pts. treated with azathioprin/steroids, 8 of IS pts. showed no immune
response and remained negative for hepatitis B antibody, in another 5
pts. hepatitis B antibody titers became positive only temporarily, while
in the remaining 2 pts. (2/15 = 13%) a significant and lasting response
was observed. Of 9 pts. treated with CsA monotherapy (no steroids). 6
showed no response and 3 responded only temporarily. Conclusion:
Despite a high dose vaccination for hepatitis B, only 2 of 15 renal
transplant recipients under conventional immunosuppressive therapy,
but none of 9 pts. under CsA monotherapy responded to the vaccine
with significant and lasting production of antibodies against hepatitis B.
Therefore, in pts. with end—stage renal disease, hepatitis B vaccination
should be done prior to transplantation. CsA treatment does not alter
this policy.
Computer modeling of extra- and intracellular volume changes during
hemodialysis of stable chronic patients. Binswanger U, with the technical
assistance Winter A, Zbinden M. Nephrologische Station, Department
für Innere Medizin, Universitdtsspital Zurich, Switzerland. Volume
changes during hemodialysis treatment (2, 5—5 hours; 2—3 treatments
weekly; filter surface 1—2 m2) were calculated by means of a single pool
model according to Petitclerc et al (Rostock—Warnemünde Symposium,
1982). The data base included initial weight, ultrafiltrate volume (
weight), initial and final plasma sodium by specific electrode (AVL, CV
= 0, 3%), hematoerit, serum protein, urea clearance, treatment time
and blood flow. Dialysate sodium was 140 mmol/liter. Results were as
follows (m, range)
N = 16; ml BTI2O* % ECV %
z
ICV %
mean —1460
—4,4 —1390 —10,8 —70 —0,5
range mm. —300 —1,2 —400 —5,5 —700 —3,0
max. —2200
—6,8 —2400 —17,1 +300 +1,3
* total body water
All treatments were well tolerated clinically. From these data it can he
concluded that a majority of patients exhibit small changes of the
intracellular lluid volume, which might explain good treatment toler-
ance; dialysate sodium modeling as a measure to influence changes of
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intracellular volume seems not to be mandatory for a great number of
chronic patients.
The value of renal biopsy (RB) in acute renal failure (ARF). Burger
HR, Gasser J, Keusch G, Otto R, Binswanger U, Institut für
Pathologic, Department für Innere Medizin und Institut für Radiologie,
Universitatsspiial Zurich, Switzerland. Percutaneous RB may provide
useful diagnostic and prognostic information, which has to be compared
to its risk. In order to evaluate the significance of percutaneous RB in
ARF, 35 biopsies of patients were analyzed. RB was performed by an
ultrasonic guidance technique in which the needle is visualized contin-
uously throughout its placement. In 20 instances, a special biopsy
needle (0 0,95—1,2 mm) was used. 15 biopsies were performed with a
conventional biopsy needle (0 2,5 mm). With both types of biopsy
needles, adequate renal tissue for diagnosis could be obtained. This new
ultrasound—controlled fine needle biopsy has been applied in more than
100 renal biopsies with only two severe complications: once a
macrohematuria and once a significant renal hematoma. In 49% of ARF
the suspected clinical diagnosis could be confirmed. In 51% the RB
revealed a clinically unexpected finding. Morphological findings were
the following: extracapillary proliferative glomerulonephritis (GN) was
in 16 of 35 cases, vasculitis in 3 of 35, thrombotic mieroangiopathy in 3
of 35, tubulointerstitial process in 12 of 35 (5 acute tubular necrosis
included), and in one case no lesions. In 58% of all cases, the
morphologic diagnosis had a direct influence on the therapeutic proce-
dure. The course of renal failure was mainly determined by the site of
lesion: in all patients with tubulointerstitial disease the renal function
improved and no patient died. On the other hand, 13 of 16 patients with
GN and 3 out of 6 patients with vascular lesions developed terminal
renal failure or died within three months. In rapidly progressive GN
with extracapillary proliferation, application of a semiquantitative score
system allowed an estimation of prognosis. In contrast, no estimation of
prognosis could be made by evaluation of the degree of the extracapil-
lary proliferation alone. We conclude, that renal biopsy has an impor-
tant diagnostic and therapeutic value in ARF. Moreover, an estimation
of prognosis can be made within a relatively short period of time
compared to clinical parameters. It seems that the risk of RB can be
diminished using a special fine needle in an ultrasound guided puncture,
with comparable diagnostic results.
Renal effects of indomethacin and dopamine in newborn rabbits.
Duarte—Silva M, Gouvon JB, Guignard J—P, Service de pediatric,
CHUV, Lausanne, Switzerland. Indomethacin is commonly used to
achieve pharmacological closure of the ductos arteriosus. Conflicting
and inconclusive results have been reported describing renal side
effects, such as a decrease in urine output, in creatinine and inulin
clearance, and in free—water excretion. The renal effects of indometh-
acm (2 ing/kg i.v.) were evaluated in 8 anesthetized, mechanically
ventilated rabbits (age 6.1 0.4 days). The experimental protocol
successively included a one—hour control period (C) and two one—hour
periods (I, II) following indomethacin administration. Body tempera-
ture, blood pH, P02 and PCO2 were maintained constant throughout the
experiment. Blood pressure (BP), urine output (V), inulin clearance
(OFR), PAH clearance (RBF), renal vascular resistance (RVR) and
fractional sodium excretion (FeNa) were recorded. Significant changes
(percent) from period C to period I and 11 were noted in BP, (+ 10%), V1
(—33%) and V11 (—59%), GFR1 (—38%) and GFR1 (—54%), RBF1
(—45%) and RBF1 (—61%), RVR1 (+96%) and RVR1 (+ 187%). 1 a
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second group of 8 animals given iv. indomethacin, dopamine was
infused throughout period land 11 at a rate of 4 j.glkg mm. The overall
renal effects of indomethacin were not significantly modified by dopa-
mine, and the Ibllowing changes were still present: BP11 (—8%), V1
(—26%) and V11 (—42%), GFR11 (—41%), RBF1 (—24%) and RBF11
(—41%), RVR1 (+32%) and RVR11 (+68%). FeNa1 and FeNa11 de-
creased by 18% and 23%. It is concluded that indomethacin induces
intense vasoconstnction in the developing rabbit kidney, and that this
effect is not significantly modified by concomitant dopamine adminis-
tration.
Tetraethylammonium (TEA) transport by a pig kidney cell line (LLC-
PK1). Christine Fauth, Bernard Rossier and Fran co/se Roe/i—Rome!,
Institut de Pharmacologic de I' Université 1e Lausanne, CH 1005
Lausanne, witzer1and. LLC-PKI cells were grown on Petri dishes for
four to five days. then cells were detached by mechanical treatment,
washed and suspended in Dulbecco's phosphate buffered saline to
measure l4C-TEA uptake. After 30 win incubation in the buffer
containing '4C-TEA and I-l-inulin, in presence or in absence of quinine
sulfate (a specific inhibitor of cation transport), the cell suspension was
centrifugated through oil and the radioactivity in cell pellets and in
medium counted. Uptake of '4C-TEA was 7.7, 18.1 and 22.4 nmoles/mg
protein at l0—, 5.l0 and I0 si TEA, respectively. By estimating the
intra- and extracellular fluid, using tritialed water and 4C-inulin, in
parallel experiments, the concentration ratio "cone. in cell water/cone.
in incubation medium" was calculated to be around 14. Quinine sulfate
at the concentrations of i0 and 10 vi inhibited TEA uptake by 16
and 84%, respectively. Cells grown on a filter glued to a lucite ring
transported '4C-TEA from basolateral to apical side. This transport was
also inhibited by quinine sulfate. These data demonstrate that this cell
line, besides phosphate, glucose and amino acids, arc able to transport
organic cations.
Correlation of delayed cutaneous hypersensitivity and in vitro lympho-
cyte stimulation in end—stage renal disease patients and following renal
transplantation. Frei D, Jeannet M, Louis F, Ruedin P, Favre H,
Département de M'édecine, Hdpital Cantoiutl Universitaire, Genéve,
Switzerland, The purpose of the present study was: I) to compare the
inhibition of cell—mediated immunity among end—stage renal disease
patients and post renal transplantation and; 2) to determine whether or
not there is a correlation of in vivo and in vitro cellular immunity in
these patients. Twenty—four renal allograft recipients ('IP), 16 uremic
patients maintained on hemodialysis (HO), 6 uremic patients main-
tained on continuous ambulatory peritoneal dialysis (CAPD) and 31
normal control persons (CO) were studied for skin responses to
delayed—type hypersensitivity (DTH) antigens using the standardized
Multitest multipuncture device, and for in vitro reactivity of their
lymphocytes to standardized antigens and unspecific mitogeos. The in
vivo results showed significantly depressed cellular immunity in all
patient groups compared to the CO (P < 0.001) with growing intensity
of depression in the following order: CAPI), HI), TP patients. The in
vitro results were similar in all goups and in the CO. When in vivo and
in vitro antigenic stimulation responses were compared, a qualitatively
and quantitatively significant correlation was found (P values for
responses stratified according to the number of positive tests between
<0.05 and <0.005, P values of significant Spcarman's rank correlation
coefficients between <0.05 and <0.002, P values of significant linear
regression coeflicients between <0.05 and <0.001). Thus, the in vivo
skin Multitcst is an appropriate method for measuring cell—mediated
immunity in end—stage renal disease patients and following renal
allotransplantalion. It is simple and seems to be more efficient than the
in vitro stimulation test in quantifying cellular ilnmunocompetence
among renal patients.
The role of HLA-DR and of a positive B cell crossmatch in 102 highly
sensitized kidney graft recipients. Frte'i D, Jeannet M, Unite dim-
inunologie de Transplantation er laboratoire de référence pour
l'histocompajibijitC Hdpital Lantonal Universitaire, GenCve, Switzer-
land. The purpose of the present study was to determine the influence
of HLA-DR compatibility and of a positive B cell crossmatch(B XM+)
on the survival of renal allografts in highly sensitized recipients (pres-
ence of anti-Hl.A antibodies active on more than 50% of the panel
lymphocytes). In the total group of 102 hyperimmunized recipients as
well as in the first grafts only, the number of lILA-DR antigens identical
among the patients and their donor (I and/or 2 vs. 0) was significantly
higher in the patients with functioning grafts (P < 0.05). Using a long
incubation assay, B XM tests have been done on fresh donor B and T
lymphocytes separated from the spleen in 54 highly presensitized
patients. Twenty—two patients had a B XM+ and 25 had a B XM—. In
7 cases, the test was a technical failure. Actuarial graft survival at
3 months and 12 months was 76%/69% in the patients with a B XM-f
vs. 7t%/64% in the patients with a B XM— (P NS). Forty—eight
hyperimmunized recipients not tested for B XM had a similar actuarial
graft survival with 77%/67% at 3 months/l2 months. Among the patients
with a B XM+, 7 also had a T XM-f (long incubation assay) and 3 had
B and T lymphocytes autoantibodies. When stratifying the data for first
grafts only, actuarial graft survival at 3 months/12 months was even
slightly better for first grafts in patients with a B XM+ than with a B
XM— (79%/70% vs. 67%/58%, P = NS). Thus., I) HLA-DR compati-
bility is significantly correlated with better allograft survival in hyper-
immunized recipients, and 2) graft survival in highly sensitized patients
with a B XM+ is at least as good as that in patients with a B XM—,
suggesting that renal allografts may be performed with a good chance of
success in the presence of a B XM+, even in highly sensitized patients.
Tenoxicam and renal function; a prospective study in a high risk
population. Giovannoni JL, Zender R, Hu,nair L, de TorrentC A,
Hdpiro! Communal, 2300 La Chaux—de—Fonds, Switzerland. Non-
steroidal anliinfiammatory drugs (NSAID) may cause alterations in
renal function especially in the aged, in patients with congestive heart
failure, cirrhosis of the liver or prior kidney disease. Twenty mg/day of
tenoxicam (T), a new oxicam derivative, was given to 10 patients (pts)
who needed a NSAID and who were at risk for renal complications.
Before and after 6 days ofT GFR, RPF (measured by Cr5' EDTA and
I 125 hippuran clearances respectively), serum and urinary for B2 micro-
globulin and plasma creatinine (Crpl) were measured. No known
nephrotoxic drugs were administered during the study. No changes in
weight or in cardiac function occurred. After T, GFR decreased in all
pts except one by --13% t 3.6% (range 3.7 to 31.3% P <0.001 by r-test)
from 91.3 16.7 mI/mm. to 81.8 16.7 mI/mm. Crpl increased from
90.5% 6.9 to 95.5 8 jimol/liter (NS). The incresae in Crpl failed to
reach significance due to the unexplained decrease of Crpl by 34% in
one pt after T, and to the fact that Cr5' EDTA clearance is a more
sensitive measurement of changes in GFR than variations of Crpl.
Other parameters of renal function did not change after T. In summary,
T induces a highly significant, albeit small, decrease in GFR in a high
risk population. The mechanism by which I causes a decrease in GFR
in high risk patients Cannot he answered by the study. inhibition of
prostaglandin synthesis with some reduction in RPF in certain pts
and/or a decrease in the filtration coefficient (Kf) may he operative.
Plasma arginine—vasopressin levels during infusion of synthetic atrial
natriuretic peptide on different sodium intakes in man. Gnddinger MP,
Weidmann I', Rascher W, Lang RE, Hellmfiller B, Uehlinger DL,
Medizinische Polik/inik, University ofBerne, Switzerland, and Depone-
mnenr of Pharmacology, University of Heidelberg, Federal Republic of
Germany. Mechanisms involved in the diuretic action of the recently
discovered group of atrial natriuretic pcptides IANPI are not entirely
clear. '1o investigate whether the increase in the renal clearance of free
waler caused by a-human [hi ANP may involve a concomitant modifi-
cation of circulating arginioe—vasopressin [AVPI, we evaluated in 10
normal subjects on sodium INai intakes of 17,140, and 310 mEq/day,
respectively, the effects of synthetic cshANP on plasma ahANP, AVP,
electrolyte, protein and hernatocrit values, blood pressure [BP] and
urinary Na and water excretion. Plasma ahANP levels before and
during a 45 mm ahANP infusion [0.09 g/kg/min] tended to be slightly,
although not significantly, higher on "normal" or high than on low Na
intake. ahANP produced on all Na intakes a slight fall in diastolic BP
[P < 0.00II. ahANP induced larger increases in hematocrit, diuresis [P
<0,0011 and natriuresis [1-' < 0.001] on a high than on low Na intake,
while the ratio between excreted fluid [in ml] and Na [in mF.q] was
much higher [I' < 0.05] on low than on "normal" or high Na diet
[mean SEM, 428 124. 13 2and II I. respectively]. Plasma AVP,
Na' and potassium concentrations were not significantly modilied.
These data indicate that in normal humans, marked changes in plasma
ahNAP concentrations have, regardless of Na intake, no relevant
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influence on circulating AVP. nhANP promotes free water excretion by
its actions at the renal level.
Renal effects of aminophylline and caffeine in newborn rabbits. Gouvon
JB, Duane-Si/va M, Guignard, J—P, Service de pediatric CHUV,
Lausanne, Switzerland. Aminophylline (theophylline ethylene—
diamine) and caffeine are widely used for the treatment of apnea in
premature infants. The renal effects of aminophylline (8l% theophyl-
line) and sodium benzoate caffeine were evaluated in 36 anesthetized,
mechanically ventilated newborn rabbits aged 4 to 10 days (BW 86-157
g). The experimental protocol successively included a one—hour control
period (C) and two one—hour periods (I, 11) after intravenous adminis-
tration of the methylxanthine. Body temperature, blood pH, P02 and
PCO2 were maintained constant throughout the experiment. Blood
pressure (BP), urine output (V), inulin clearance (GFR), PAH clear-
ance. sodium fractional excretion (FeNa) were measured and the renal
vascular resistance estimated by the ratio BP/renal blood flow.
Aminophylline was administered at a dose of 3 mg/kg (group I) and 6
mg/kg (group 2); caffeine at a dose of 5 mg/kg (group 3) and 10 mg/kg
(group 4). Significant changes (percent) from period C to periods I and
II were observed in group I: GFR11 (—51%), RVR11 (+119%); in group
2: BP1 (+10%), V1 (+69%), GFR1 (+32%), RVR11 (+122%), FeNa1
(+91%); in group 4: BP1 (+7%), V1 (+77%), V11 (+69%), GFR1 (+33%),
RVR11 (f 33%). No significant changes were observed in group 3. The
renal effects of both aminophylline and caffeine appeared, at least
partially, dose—related. The renal vasoconstriction was most striking in
the group receiving aminophylline. The mode of action of the
methylxanthines is complex, and the resultant hemodynamic renal
effects can depend upon a direct effect on vascular tissue, or indirect
peripheral actions mediated by cathecolamines, and possibly by the
renine—angiotensin system.
Centrifugation of 50 ML of peritoneal fluid is sufficient for microbio.
logical examination of CAPD peritonitis. Haechler H, Binswonger U,
VOfl Graevenitz A, Department of Med. Microbiol. University of
Zuerich, and Nephrology Section, University Hospital of Zuerich,
Switzerland. Peritonitis is a major problem in CAPD. For detection of
low count bacterial infections concentration of dialysis fluid is recom-
mended. A prospective study was undertaken to determine the optimal
volume of fluid to be centrifuged for a maximum yield of microorga-
nisms. From 28 dialysate bags representing 17 episodes of peritonitis in
10 patients, samples of 50 nil and 1000 ml, respectively, were centri-
fuged at l200xg for 10 minutes. The pellets were subjected to microbi-
ological examination using solid media for aerobic and anaerobic
incubation and enrichment broth. Of the 28 samples, 27 50 ml pellets
(96%) showed identical results with the 1000 ml pellets; only in one of
28 samples did the 1000 ml pellet yield growth (in the enrichment only)
while the 50 ml pellet did not. These data suggest that it is unnecessary
to centrifuge more than 50 ml of fluid. Our data further implicate that,
without any influence of the volume of the sample, the chance of finding
the pathogen is greater if more than one sample per episode of
peritonitis is taken: 19 of the 28 cultures (64%) yielded growth, but 12
(70%) of the 17 episodes represented by these 28 samples could be
explained by a pathogen. In only 5 of 8 episodes (62%) represented by
a single sample microorganisms could be isolated, while growth was
found in 7 of 9 episodes (77%) represented by 2 or more samples. In
addition, the rate of positive cultures was significantly higher (14 of 17
vs. 5 of 11, P < 0.05) if samples were taken before administration of
antibiotics.
Effects of human atrial natriuretic peptide (ahANP) on kidney function
in man. Has/er L, Weid,nann P, Gnadin gee MP, Lang RE, Uehlinger
DE, Shaw 5, Rascher W, ReubiFC, Medizinische Polik/inik, University
of Bern, Switzerland, and Dept. of Pharmacology, University (f
Heidelberg, Federal Republic of Germany. To investigate renal effects
of nhANP in man, we measured in 10 normal subjects effective renal
plasma flow (ERPF), glomerular filtration rate (GFR), electrolyte ex-
cretion, free water clearance (CH2O), blood pressure (BP). plasma
ahANP and other factors before, during and after a 45 mm infusion of
synthetic nhANP, 0.1 rg/kg/min. hANP-infusion increased plasma
ahANP from 58 12 to 625 87 1± SEM) pg/mI, caused an immediate
fall in diastolic BP (—12%, P < 0.001) and rise in hematocrit (+7%, P
<.01) largely unexplained by diuresis. It increased GFR (+ 15%) despite
unchanged or decreased ERPF (filtration fraction +37%, P < 0.001),
augmented (P < 0.05 to <0.001) chloride (+317%), sodium (+224%),
calcium (+ 158%), magnesium (+ 110%) and phosphate excretion
(+88%) and CH2O (from —0.76 to +2.23 mI/mm) with minimal change
in potassium excretion. It also increased plasma norepinephrine (P <
0.001), while free dopamine, epinephrine. ADH, angiotensin II and
aldosterone levels were not significantly changed. Therefore, in normal
man ahANP can promote an extravascular shift of fluid and augment
GFR, despite a BP reduction and tendency for decreased ERPF.
ahANP enhances CH2O with unaltered circulating ADH. The pattern of
ahANP-induced diuresis and electrolyte excretion may reflect both
glomerular and tubular mechanisms.
The role of complement in the reversal of hemodialysis induced
neutropenia on four different membranes. Heierli C, Markert M,
Lambert PH, Woofers JP, Division de NCphrologie, Hopital
Universitaire, Laasanne, Switzerland. The neutropenia induced by
different dialyzer membranes has been linked to activation of the
complement system. Reversal of this phenomenon despite continuation
of dialysis was explained on cuprophan by selective down—regulation of
neutrophils (PMN) to activated complement. To investigate this phe-
nomenon aggregation (Agg) of dialyzed PMN was studied at time 0 and
60 mm after start of dialysis with four different membranes: cuprophane
(CU), cellulose acetate (CA), polysulfone (PS), and polyacrilonitrile
(PAN). Plasma drawn from the venous blood line at the maximum PMN
drop and enhanced by cytochalasine B was used as stimulus to test Agg
of PMN after lung capillary entrapment. Results of Agg essay were
expressed as % of Agg at time 60 mm when compared to time 0 mm.
CU CA PS PAN
PMN (N = 10) 6 1% 49 9% 79 9% 83 12%
% max. neutropenia
C3d (N = 10) 1.4 0.2 1.2 0.3 0.5 0.3 0.3 0.2
ng/100 nil
Agg (N = 3) 40.5% 70.5% 94.1% 46.3%
For CU, the down—regulation was less than previously described; for
CA it is slight while neutropenia and complement activation are
important: there was no change in Agg for PS, and for PAN nearly the
same insensitivity to Agg stimulus than for CU was evidenced despite
insignificant PMN and C3d modifications. Conclusion: The discrepancy
between the degree of neutropenia, complement activation and PMN
aggregation on the four membranes studied suggests that reversal of
hemodialysis induced neutropenia cannot be ascribed exclusively to
complement induced down—regulation of neutrophils, but is probably a
multifactorial process.
Renal involvement in legionaires disease. lieu/c H, Reutter FW, Gloor
F, Medizinische K/in/k B and Institut für Pathologic, Kantonsspilal,
9007 St. Ga/len, Switzerland. In eight consecutive cases of legionaires
disease, urinary sediment was either abnormal or there was acute renal
insufficiency. In one case, the urine abnormalities were explained by
preexisting diabetic glomeruloselerosis and the existing terminal renal
failure by coexisting shock. In seven cases the renal abnormalities are
considered as manifestations of legionaires disease: six cases presented
acute renal failure, requiring renal replacement therapy in three, six
patients had proteinuria, four erythrocyturia and leucocyturia and two
cylindruria. One patient died because of severe pneumonia. Renal
biopsies were performed in four patients and showed acute interstitial
nephritis in one case. In three biopsies the pathology was explained by
diabetic nephropathy. chronic rejection and septic/hypovolemic shock
and could therefore not be attributed to legionaires disease. The cases
demonstrate that renal involvement is a frequent complication of
legionaires disease with a wide range of pathogenesis.
Impact of physical training on muscle function and structure in renal
transplant patients on prednisone. Horber FF, Herren H, Hoppeler H,
Howald ii, Gnilnig BE, Frey, Fi, Medizinische Poliklinik, Anato-
misches Inst it at, Orthophdische Klinik, University of Benne,
Spontschule Magglingen, Switzerland. Treatment with glucocorticoids
causes wasting of proximal skeletal muscles. Whether training—induced
changes in muscle mass, ultrastructure, and function are different in
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glucocorticoid treated patients as compared with healthy volunteers, is
unknown. Therefore, the present investigation was designed to estab-
lish in what respect a moderate physical training of the thigh muscle
during fifty days may alter muscle mass, muscle function, and muscle
ultrastructure as assessed quantitatively by computed tomography
(CT), by an isokinetic dynamoineter (Cybex II), and by a morpho-
metrical analysis by means of electron microscopy. The mean peak
torque and total work output increased by 35 21 nm (P < 0.001) and
1021 825 J (P < 0.005) in normal subjects (N = 9) and by 31 17 nm
(P < 0.001) and 876 420 J (I' < 0.001) in prednisone treated patients
(N = 9). The midthigh muscle area increased by 5.6 5.7 cm2 in normal
controls (P < 0.01) and by 6.7 5.8 cm2 in prednisone treated patients
(P < 0.001). Surprisingly, total myofibrillar volume of the thigh muscle
remained unchanged by the training in both groups of sutjects investi-
gated. The increased midthigh muscle area, observed by CT, was
mainly attributable to an increase in intracellular glykogen of 5.6 2.3
cm2 (P < 0.01) in normal controls and of 4.8 4.6 cm2 (P < 0.001) in
prednisone treated patients. Although an anaerobic form of training was
performed (VO2m,,., remained unchanged during the training), intracel-
lular content of mitochondria increased by more than 20% in patients
treated with prednisonc (P < 0.005), whereas in normal controls no
increase in mitochondria volume was found. In conclusion, normal
controls increase their muscle efficiency by increasing intracellular
glycogen content, whereas prednisone—treated renal transplant patients
increase both intracellular glycogen and mitochondria content during a
physical training.
Parathyroid hormone directly inhibits tubular reabsorption of bicar-
bonate in normocalcemic—nermophosphatemic rats with chronic hyper-
parathyroidism. Jaeger Ph, Jones W, Ka.shgarian M, Segre GV,
Hayslett JP, Lausanne, Yale and harvard Universities, Lausanne,
Switzerland, New Haven, Boston, Massachusetts, USA. The hypoth-
esis that chronic inetabolis acidosis encountered in some patients with
primary hyperparathyroidism is due to inhibition of proximal HCO
reabsorption has recently been challenged. Indeed, this action of
parathyroid hormone (PTI-1) has only been observed in acute studies,
whereas in animal models of chronic hyperparathyroidism, a metabolic
alkalosis has been induced, probably owing to the release of alkaline
salts from bone tissue by the hormone, and to the stimulation of tubular
acid secretion by hypercalcemia. Studies were therefore performed to
determine the effect of PTH on the renal handling of I-lC03 in an animal
model in which changes in serum calcium and phosphorus, and neph-
roealcinosis, all known to affect tubular acidification, did not occur.
Thyroparathyroidectomized (TPTX) rats were infused with synthetic
bovine hormone fragment 5PTI-T 1-34 via Alzet mini-pumps at the rate of
0.7 U hr-1 to simulate normal endogenous production of PTH (Group
l)and at the three-fold higher rate of 2.1 U hr '(Group 11). To prevent
changes in serum calcium and phosphorus, and nephrocalcinosis,
animals of group II were fed a Ca- and P-free diet prior to TPTX
(compared with a regular diet for group I) and both groups were treated
with dichioromethylene—diphosphonate (CI2MDP, 10mg kg- ' day')
and a Ca-free diet during PTFI infusion. During the course of PTH
infusion, both groups of animals had similar stable and normal levels of
serum calcium and phosphorus. Although systemic acid—base parame-
ters and urinary pH and HCO values were similar in animals with
normal and elevated PTH levels under basal conditions, isovolemic
bicarbonate loading carried out by peritoneal dialysis revealed a signif-
icant increase in urinary pH (7.37 0.06 vs. 6.29 0.06 vs. 6.29 0.29,
P <0.005) and fractional bicarbonate excretion (0.52 0.11 vs 0.03
0.02%, P < 0.005) in the group with hypcrparathyi-oidism. These data
provide evidence that chronically administered parathyroid hormone
directly inhibits tubular reabsorption of HCO3. They suggest that in
clinical hyperparathyroidism l-1C03 wasting results from excess secre-
tion of the hormone.
Anticystinuric effect of glutainine (Gin). Jaeger Ph, Port,nann I.,
Saunders A, Rosenberg L-E, Thier SO, Universities of Lousanne,
Switzerland, and Yale, New Haven, Massachusetts, USA. We had
recently observed that Gin administered orally to one patient with
cystinuria had an anticystinuric effect, thus confirming previous results
obtained by Miyagi in another patient. Although the mechanism had
remained unelucidated, we had noted that a high Na-intake was a
feature apparently shared by the two "responders" to GIn. To further
investigate this aspect, one patient with cystinuria received L-Gin (3 x
0.7 g/day) for 30 days on both his regular(l60 mmol/day) and a high (300
mmol/day) Na-intake. On 300 mmol Na/day, GIn depressed
UCystine . V from 2.99 0.14 (3) (X SEM, N) to 2.34 0.18 (4)
mmol/g creat (P < 0.025), but on 160 mmol/day it did not. An
additional finding was that UCystine V was higher on high— than on
regular Na-intake: 2.99 0,14(3) vs. 2.09 0.15 (3) mmol/g- creat, P
< 0.01. A plot vs. UNaV of the individual values of UCystine V
obtained in 5 cystinurics disclosed a positive correlation between both
parameters (r 0.82, N 33, P < 0.001). Similar correlations were
found for the other 3 dibasic aminoacids (ornithine, Lys, Arg), but not
for Asn, Glu, Gly, Ala, Val, Met, Lcu, Phe and His; these correlations
were abolished on Gin. As a corollary, to evaluate the maximal benefit
that cystinurics would expect from Na-restriction, three such patients
received for inure than two weeks a diet providing less than 50 mmol
Nalday, and data were compared with those obtained on a regular diet.
In each case, UCystine V decreased significantly, from 3.66 0.17
(10) to 2.17(1) mmol/24 hr, P <0.025, in patient l,from 2.65 0.10 (3)
to 2.03 0.14 (4) mmol/24 hr, P < 0.02, in patient 2, and from 1.84 1
0.08 (3) to 1.63 0.03 (5) mmol/24 hr, P < 0.05, in patient 3. 'l'he
anticystinuric effect of the low Na diet was not additive to that of Gin.
Since solubility 01' cystine in urine is about 1.25 mmol/liter at p1-I 4.5 to
7, and since all 24 hr urine volumes were larger than 1.8 liter, it appears
that cystine concentration was well within the safe range in each sample
obtained on the low Na diet. Conclusion: Gin reduces cystine excretion
of cystinurics in states of high Na-intake only. There is, however, a
Na-dcpcndant excretion of cystine which provides a safe therapeutical
alternative.
Immunosuppressive therapy with low—dose cyclosporine, azathioprine
and steroids in cadaveric renal transplantation. Keusch G, Burger HR.
Uhlschmid G, Krayenhdhl J, Largiadër F, Binswanger U. Universitilts-
.spital Zil rich, Switzerland. In order to avoid side effects of eyelosporinc
(Cs), azathioprine (Aza), and prednisone (P) and to improve the results
in renal transplantation (RT), we studied an immunosuppressive regi-
men with low—dose Cs, Aza and P in 56 consecutive cadaveric RT
performed in 1984. Cs was started with 5 mg/kg/day and thereafter
adjusted to keep whole blood trough level between 200 and 600 pg/nil.
Aza was given in a dose of 1 mg/kg/day. P was administered in a dose
of 1 mg/kg/day for the first two weeks, and thereafter reduced in
monthly intervals by 10 mg. At six months after grafting P was
discontinued, if tolerated. As control groups, 51 RT perl'ormed in 1983
and 58 RT performed in 1982 treated by conventional immunosuppres-
sion with Aza and P were analyzed: Results: actuarial survival rates
were as follows:
Patients grafts
0—I 1—3 3—6 6—12 0—1 1—3 3—6 6—12
mo mo mo mo mo mo mo mo
1984
1983*
1982
98%
98%
98%
98%
96%
95%
95%
96%
93%
95%
96%
93%
91%
90%
84%
91%
84%
79%
86%
82%
72%
84%
82%
60%
* in 7 pts Cs was given 7.7 2 mo after RT because of repeated
rejection episodes
Sixteen of 56(29%) pts. treated with Cs and 17 of 51 (33%) pts. treated
with conventional therapy in 1983 experienced post-transplant acute
tubular necrosis (ATN). The onset of adequate renal function
(serum—creatinine <400 pmol/liter without dialysis) was 18 6 days in
the Cs-treated pts. and 18 6 days in the conventional treated pts. after
grafting, respectively. In six of 37, renal biopsy specimen from 23 pts.
histological lesions compatible with Cs nephrotoxicity were found. The
corresponding Cs trough levels ranged from 363 to 1127 (mean 708)
ng/ml. Conclusions: Low—dose triple immunosuppressive regimen was
found to improve the results in cadavcric RT, associated with few side
effects, The incidence of post-transpiant ATN was comparable in both
treatment regimen and the onset of adequate renal function was not
delayed in the Cs-treated patients.
De novo hemolytic uremic syndrome in two renal allograft recipients
treated with cyclosporine: Successful therapy with plasmapheresis.
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Keusch G, (Jrndr J, Baurngartner D, Burger HR, Largiadèr F,
Binswanger U, Univcrsitdtsspita/ Zurich, Switzerland. Hemolytic ure-
mic syndrome (HUS) has been reported in bone—marrow and liver
transplant recipients treated with Cyclosporine (Cs). Recurrence of
HUS following renal transplantation (RT) has rarely been observed. We
report on two cases of de novo HUS in renal transplant recipients
treated with Cs, Prednisone (P) and Azathioprine (Aza). The underlying
kidney disease was in both cases an analgetic nephropathy. Case 1: A
53 year old woman remained oliguric after a third cadaveric RT under
immunosuppression including P (50 mg/day), Aza 650 mg/day) and Cs (6
mg/day) and necessitated hemodialysis treatment during three weeks
postoperatively. On the fifth day after grafting the platelet count fell
from 582 to 51 109/liter and a microangiopathic hemolytic anemia
(serum-LDH 5027 U/liter, 91 0/00 fragmented red cells in the peripheral
blood smear) was disclosed. Transplant biopsy revealed glomerular and
arteriolar thrombosis and tubular injury. The whole blood Cs trough
level was 1125 ng/ml on the tenth day after grafting. Plasma exchange
(50 mI/kg) on a cell separator was started and plasma removed was
replaced with fresh frozen plasma. After 10 plasma exchanges and
adjustment of Cs trough level between 200 to 600 ng/ml, HUS resolved
two weeks later. Serum—creatinine fell below 400 timol/liter without
dialysis 26 days after grafting. At 14 months, serum creatinine was 140
mol/liter. Case 2: A 59 year old man developed six days after a second
RT acute non-oliguric renal failure under immunosuppression with P
Aza and Cs (5 mg/kg/day). Thrombocytopenia (48 109/liter) and
microangipathic hemolytic anemia (LDH 5705 U/I, 186 0/00 fragmented
red cells in the peripheral blood smear) were observed. Cs trough level
was 441 ng/ml. The absence of graft swelling (in ultrasonic scan) and of
fever made acute transplant rejection unlikely. A transplant biopsy was
not performed because of the low platelet count. Withdrawal of Cs
combined with seven plasma exchanges and two hemodialysis were
followed by recovery of hematological abnormalities after six days and
renal function after two weeks. At nine months serum creatinine was 98
rmol/liter. Conclusions: Cs may cause de novo HUS in renal allografts.
Therapy with plasmapheresis looks promising.
Atrial natriuretic peptide release in man: Controlled by wall stretch
and volume. Md/Icr FB, Bock A, Raine AEG, Erne P. Resink TJ,
Kiowski W, Bolli P, Thiel G, Brunner F, BOhIer FR, Dh'isions of
Cardiology and Nephrology, University Hospital, Basel, Switzerland.
To investigate the atrial natriuretic peptide (ANP) release into the
human circulation, plasma concentrations and the effects of volume
changes were studied in 39 normal subjects, in 26 patients during
diagnostic cardial catheterization and in 17 patients with chronic renal
failure. A new radioreceptor assay with a detection limit of 2
fmoles/tube for alpha-hANP was used. Plasma ANP in 18 normal
subjects was 32 6 (sEM) pmol/liter (range 6 to 65). Plasma ANP in
seven normal subjects after 14 days was on a low sodium diet 33.2
10.2 (UNAV 55 14 mmol/24 hr), on normal salt 20.3 3.1 (UNV 119
29) and following salt loading 8.9 3.0 (UNaV 325 44). In another
seven subjects undergoing head—out water immersion ANP increased
from 16.0 5.6 to 40.6 13.6 in the first, to 92.6 21.5 (P < 0.01) in
the second and remained at 87.4 23.3 (P < 0.01) in the third hour (59.3
17 during recovery). Urinary sodium excretion rates followed this
plasma ANP pattern. Predialysis ANP in 17 patients with end—stage
renal disease was significantly higher than in healthy subjects. During
hemodialysis plasma ANP decreased significantly from 123.3 30 to
50.2 8.3 and plasma renin rose from 8.5 2.7 to 14.4 4.7. In the 26
patients undergoing cardiac catheterization, there was a direct relation-
ship between right atrial pressure and right atrial ANP (r = 0.835, P <
0.01) and between pulmonary wedge pressure and atrial ANP (r =
0.866, P < 0.01). A 1 mm Hg rise in atrial pressure was associated with
a 13.6 pmol/l increase in atrial ANP. In man changes in atrial wall
stretch consequent to changes in atrial volume and perhaps hormonal
control regulate ANP release and plasma concentrations thereby pos-
sibly contributing to natriuresis and vascular tone.
Outcome of renal transplantation after continuous ambulatory perito-
neal dialysis or hemodialysis treatment. MOller U, Keusch G,
Binswanger U, Nephrologische Station, Dept. für Innere Medizin,
Universitdt Zurich, Schweiz. In order to assess the influence of modal-
ities of dialysis treatment upon the outcome of renal allotransplantation
(RT) we analysed 87 cadaveric RT performed in 1983 and 1984. Before
RT 63 pts. had been treated with HD and 24 pts. with CAPD,
respectively. The clinical characteristics of the Iwo groups were as
follows (mean SD):
CAPD
HD group group
age (years) 41 12 42 9
diabetic nephropathy 1/63 6/24
duration of dialysis (years) 3.3 2.5 1.7 1.0
39 pts. transplanted in 1983 were treated with conventional immunosup-
pression (29 HD group, 10 CAPD group), 48 pts. transplanted in 1984
received CyA and prednisone. The graft survival in both treatment
groups were: (%)
Year
I
83
mo.
84
3
83
mo.
84
6
83
mo.
84
12
83
mo.
84
HD group 93 98 92 96 89 96 89 96
CAPD group 90 93 90 86 90 71 80 71
Graft losses were due to rejection in four of six patients after HD and
three of six patients after CAPD. Graft survival was similar after CAPD
vs. HD, a finding not universally accepted in the literature.
Renal functional state and dietary sodium intake in normotensive
members of normotensive or hypertensive families. Pus icr/a C, Stddler
P, Beretta—Piccoli C, Wirth H, Ospedale Italiano, Viganello, Switzer-
land. Certain renal abnormalities have been noted in normotensive
members of hypertensive families and could represent familiar compo-
nents in the pathogenesis of essential hypertension. Whether and to
what extent such disturbances depend on sodium balance is investi-
gated in this study. Eight normotensive men without and 10
normotensive men with family history of essential hypertension (FH),
aged 20 to 32 years, had a constant infusion clearance study at the end
of a seven day period of low sodium diet (urinary sodium IS 19
mmol/24 hr SD) and after seven days of high sodium diet (urinary
sodium 281 108 mmol/24 hr) without variations in potassium intake
(80 24 vs. 75 17 mmol/24 hr). Under low sodium conditions, the two
groups did not differ in body weight, arterial pressure (112/69 13/10
vs. 117/75 12/l0mmHg)andtheclearancesofinulin(l44 l8vs. 146
21 mI/mm), PAH (640 95 vs. 677 220 mI/mm), sodium (0.4 0.3
vs. 0.3 0.3 mI/mm), potassium (21 9 vs. 22 11 mI/mm), lithium (21
17 vs. 19 12 mI/mm) and uric acid (II 2 vs. 12 4 mI/mm).
Fractional clearances of sodium, potassium and lithium were also
similar. After high sodium intake, body weight, (+ 1.5 kg) and sodium
clearance (to 1.9 1.3 and, respectively, 1.8 0.8 mI/mm) increased
significantly (P < 0.05) in both groups; blood pressure increased only in
subjects with FH (±l/+ I vs. + l0/+5 mm Hg). The clearances ofinulin,
PAH, potassium, lithium, and uric acid as well as the fractional
clearances of potassium and lithium did not change. These findings
suggest that proximal tubular reabsorption of sodium, as estimated by
the lithium clearance, and absolute reabsorption of sodium from the
distal nephron are not altered in subjects with FH under conditions of
low or high sodium intake.
Mechanism of tetraethylammonium (TEA) transport across the rabbit
renal brush border membrane (BBM). Rafizadeh C, Roch—Ramel F,
Schdli C, Inst. de Pharmacologic de l'Universitë, 1005 Lausanne,
Switzerland. The renal tubular secretion of TEA, an organic cation,
involves successive transport across the hasolateral membrane and the
BBM. We investigated the mechanisms involved in the transport of
TEA in the BBM by using membrane vcsicles. Transport of 4C-TEA
(200 rM) was measured by a rapid filtration method. Results arc: I) at
25°C, a proton gradient (pHi = 6.0, pHo 7.4) yielded a transient
overshoot (267%) of TEA transport above the equilibrium uptake (100%
= 519 54 pmol/mg protein, N = 7) suggesting a H-TEA exchange
mechanism; 2) a valinomycin/K induced voltage clamp did not affect
this uptake; 3) this transport was temperature dependent: at 4°C the IS
sec uptake was 19% and at 37°C 161% of the 25°C values; 4) it was
saturable: Km was 261 20 rM and V,,,, was 1556 318 pmole/mg
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protein x 15 sec (N = 3); 5) it was inhibited by more than 80% by
competitive inhibitors such as mepiperphenidol or quinine (1 mat in the
bath). Another organic cation, Nmethylnicotinamide (NMN) had only
a weak effect; 6) it was specific for organic cations: p-aminohippurate
(PAH), an organic anion, had no inhibitory effect; 7) countcrtransport
was observed when BBM vesicles were preloaded with 1 mM
mepiperphenidol or TEA: the IS sec uptake values were 223% and
305% of control values, No significant effect was observed when the
vesicles were preloaded with NMN. These results suggest the presence
in the BBM of a carrier—mediated transport mechanism exchanging
protons for TEA, for which NMN has only low affinity.
Effect of physical conditioning on physical working capacity (pwc) in
patients with chronic renal failure (cr1). ROse/er E, Aurisch R, Priern F,
Prechi K, S/ran gfeld D, Matzke J, Sic wert H, Horn boldil—UniversitOt.
Bereich Medizin (Cliarité), Medi:inische Klinik, 1()40 Berlin, Schuman-
nstr. 20/2 I, German Democratic Republic. It is known that physical
fitness is reduced in relation to the severity of crf. The loss of pwc is
caused by a complex of functional disturbances and organic disorders.
Two of them are uremic myopathy and physical inactivity. The purpose
of our study was to improve patient's physical fitness by regular
physical training and to determine cardiovascular and metabolic re-
sponses to this therapeutic procedure. Sixteen patients (nine males,
seven females) at different stages of cc!' (mean creatinine serum 679
imol/liter, hemoglobin 6.64 mmol/liter) have been trained twice weekly
for 30 mm at a training load of 80% of maximal work load for 3 months.
Training significantly improved pwc (65.6 W before, 93.8 W after
training). After training, heart rate, blood pressure, cardiac output,
stroke volume, lactate, potassium, inorganic phosphate decreased at a
work load of 50 W, whereas the same parameters remained unchanged
at maximal work load. The data show that the physical fitness of
patients who undergo physical conditioning is significantly better than
that of untrained uremic patients. 'I'he cardiovascular and metabolic
reserve have been improved by training (reduction of these parameters
at a submaxima] work load). The increased pwc is not due to an
improvement of maximal cardiac output, but is caused by improved
metabolic capacity. The patients achieved their positive training effect
without any training—dependent progression of renal failure, if the
training was performed under nephrological supervision. Errors of
training (intensity, duration) can result in a deterioration of physical
fitness and renal failure.
Urinary tract infection (UTI): Clinical signs and antibody coated
bacteria (ACB). Roth D, HirschelB, Favre H, Divisions de Nephrologie
Cr des Maladies Inféctieuses HOpital Canional Universilnire tie
Genève, Switzerland. When the ACB test was first introduced, it was
supposed to distinguish upper from lower UT!, but later it appeared that
its greatest usefulness was to predict success of single dose treatment
(95% for a negative versus 50% for a positive test). in 60 consecutive
patients with UTI, the presence of one or more of three clinical signs,
that is, temperature (>38°), leucocylosis (>lO.000/mmc) and loin pain
was confronted with ACB test results. Presence of all three criteria, as
well as presence of loin pain and an additional criterium predicted a
positive ACB test (sens. 85%, sp. 100%; sens. 70%, sp. 75%, respec-
tively). Patients with fever or with leucocytosis only tended to have a
negative ACB test (sens. 85%, sp. 62%). In those 5% of patients who
presented with fever and Icucocytosis but without loin pain, the ACB
results were unpredictable. In contrast to previous reports, the duration
of the disease before admission (from 10 hours to 7 days) was not
indicative of the ACB test response. Leucocyturia did not have any
relationship to the ACB test. Conclusions: in 85% of UTI patients, the
mode of treatment (single dose versus long—term treatment) can be
decided on the basis of fever, leucocytosis and loin pain. ACB tests may
help decision making in the remaining 15% of patients.
Immunosuppression and/or plasmapheresis in the treatment of
Goodpasture's Syndrome (CS). Schmitt, E, Bahl,nann G, Funke K,
Kinzel P, Klinkmann H, Klinik fOr Innere Medizin, Wilhelm—
Pieck—Universitdt, Rostock, German De,nocratic Republic.
Hemoptysis is generally treated by I g prednisolone injections while
cyclophosphamide is administered in order to suppress the antiGBM-
antibody production. Since Lockwood first reported on plasmapheresis
10 years ago, this procedure is regarded as effective for the control of
pulmonary hemorrhage and the development of renal failure. This paper
reports on 11 cases with GS. The antiGBM-nephritis was biopsy proven
in 10 cases, whereas circulating antiGBM-antibodies were detected in
eight cases only, that is the specific antibodies were detected in every
patient, either in the biopsy specimen or in the circulation. The patients
were generally treated with prednisolone (30 to 1000 mg/day) and
cyclophosphamide or azathioprine respectively (1 to 2 mg/kg/day).
Plasma exchange was performed in seven patients. Binephrectomy was
necessary in three cases. The outcome in our patients was as follows:
four patients remained on heinodialysis, two never had any impairment
of renal function, and in four eases renal function was restored
completely. One patient died of a steroid ulcer. In all cases hemoptoe
was controlled by this regimen. Nearly all plasma exchange treatments
were carried out with membrane plasmapheresis. In all of the eight or
nine treatments per patient, an average of 3.0 liters of plasma were
exchanged. The benefit of the plasma exchange may be assessed on the
basis that in all cases but one (binephrectomy); it resulted in control of
pulmonary hemorrhage. In three cases renal function became normal,
one patient died and another three remained on dialysis. Our general
therapeutic approach is the following: basic immunosuppression is
carried out with cyclophosphamide, Ito 2 mg/kg/day and 30 to 50 mg of
prednisolone/day. Hemoptysis is treated with prednisolone up to I
g/day. In addition plasmapheresis is applied 10 to 20 times, but not if
renal function is intact.
Catecholamines in experimental ischemic renal failure. Shaw S,
Weidmann P. Medizinische Poliklinik, University of Bern, Switzerland.
Considering the interactions between catecholamines (C) and renal
function, acute renal failure (ARF) could theoretically he accompanied
by systemic and/or intrarenal accumulation of C, which in turn might
influence the course of ARF. Since no such data have been available,
circulating and renal tissue cpinephrine (E), norepinephrine (NE),
dopamine (DA) levels, and mean arterial pressure (MAP) were assessed
before and in the early phase of ARF, induced by 90 mm of arterial
clamping in 13 anesthetized (by mactin) Sprague—Dawley rats
uninephrectomized before, Free F. NE and DA were measured using
HPLC with electroehemical detection. During clamping, plasma E, NE,
DA and MAP were unchanged. Following unclamping, MAP rose 10 to
IS mm Hg. then fell slowly, stabilizing after 45 mm at 40 mm Hg below
baseline. Plasma C increased (P < 0.01) progressively IS, 45, 90, 120
mm after onclamping, F from 56 17 to 355 170 ng/dl. NE from 24
3 to 85 31 ng/dl, DA from 25 6 to 82 9 ng/dl; plasma ereatinine
rose from 0.69 to 1.44 mg/dl. In renal cortex, E rose from 35 410 154
54 ng/g protein (P < 0.01), DA from 128 14 to 202 45 ng/g (P <
0.05); NE tended to decrease from 1622 138 to 1345 140 ng/g. In
renal medulla, E rose from 38 7 to 157 38 ng/g (P < 0.01); NE (from
1408 122 to 1260 153 ng/g) and DA (114 11.5 to 140 26.5 ng/g)
were not significantly altered. Conclusion: experimental ischemic ARF
is accompanied by marked and regionally distinct abnormalities in C
with a known potential of modifying renal function.
Atrial natriuretic peptide may increase plasma insulin in man.
Uehlinger DE, Weidmann P. Gn0dinger MP, Bachmann C, Ilasler 1.,
HelimOller B, S/maw S. Medizinische Poliklinik and Dept. of Clinical
Chemistry, University of Bern, Switzerland. To search for possible
metabolic interactions of a-human atrial natriuretic peptide (ahANP),
we evaluated in 20 normal subjects blood levels of glucose, insulin,
cortisol, electrolytes, cateeholamines, free fatty acids, carnitine and
amino acids, blood pressure (BP), and heart rate before, during and
after a 45 mm infusion of synthetic ahANP. Group A (N = 10) was
studied on liberal and Group B (N = 10) on the 6th days of 3
consecutive sodium (Na') intakes of 17, 140 and 311) mEq/day. ahANP
infused at 0.1 p.g/kg/min produced on all Na intakes comparable
percentage increases in plasma insulin (on average +51 18%, P <
0.001), norepinephrine (on average +113 26%, P < 0.001) and heart
rate (+ 13%, P < 0.001) and a similar fall in diastolic BP (—9 1%, P
< 0.001); plasma glucose tended to be decreased slightly, cortisol was
reduced by 23 5% (P < 0.01), while epinephrine, dopamine, and
potassium levels were not significantly modified. ahANI' did not
interfere with the radioimmunoassay for insulin. As evaluated in Group
A, serum free fatty acids were increased (+ 159 23%, P < 0.01),
plasma free carnitine levels reduced (—34 13%, P < 0.01) and amino
acids not consistently altered. 't'hese findings indicate that in normal
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man, ahANP may on various sodium intakes elevate circulating insulin
levels and elicit a possibly baroreflex—mediated sympathetic activation
and lipolysis.
Catheter related complications during continuous ambulatory perito-
neal dialysis (CAPD): A retrospective study on 62 double—cuff Tenckhoff
catheter. Vogt K, Binswanger U, Buchinann P, Largiader F,
Nephrologische Station, Chirurgische Klinik, Universitätsspital
Zurich, Switzerland. From May 1980 to April 1985, a total of 62
double—cuff Tenckhoff catheters were surgically implanted in 54 pa-
tients. The follow—up on CAPD accounted for 1029 patient months. A
total of four exit—site infections, one tunnel infection, three outer cuff
erosions, four catheter dislocations, and one dialysate leak were
observed. In five patients, the catheter had to be removed (one exit—site
infection, two catheter breaks, and two catheter dislocations). Cumu-
lative catheter survival using the method of lifetime analysis was 81%
and 70% after one and two years, considering all removed catheters and
92% and 92% again, when peritonitis related removal was excluded.
The use of a detachable CAPD system (Zurich) together with a sterile
gauze catheter dressing, under which the external portion of the
catheter and the proximal part of the extension tubing are forming a
loop, preventing tractic forces on the catheter, has proven effective in
the prevention of exit—site and tunnel infections. The catheters were
inserted through an incision 2 cm below the umbilicus and positioned
straight into the pouch of Douglas. The were tunneled subcutaneously
over 5 cm in cranial direction, leaving the outer cuff 2 to 2.5 cm away
from the skin. The peritoneum was tightly closed, fixing it through a
pursestring suture to the inner cuff of the catheter. The fascia was
sutured separately. Dialysis was started immediately with small vol-
umes (500 to 1000 ml) and the patients kept on bedrest for the first three
days after catheter insertion.
Which factors contribute to cost containment of end—stage renal failure
therapy? Wauters JP, Spertini F, Division de Nephrologie, HOpital
Universilaire, Lausanne. Switzerland. The still increasing cost of
end—stage renal failure (ESRF) therapy raises concern in many devel-
oped countries. Based on a survey conducted in all Swiss dialysis units
and on the figures observed in our own center, the efficacy of some
factors commonly proposed to reduce ESRF costs can be analyzed:
—Patient selection: a more restrictive policy appears difficult to apply
since out of a list of 30 cases to be selected for dialysis therapy, no
single patient was accepted and no one refused in all Swiss dialysis Units
—Development of new dialysis units: by multiplying small dialysis
units, it appears that center hemodialysis becomes the only offered form
of ESRF therapy and the patient/nurse ratio stable around 5 for large
units decreases to I.
—Dialyzer re-use: a cost calculation of the dialyzer re-use process
has shown that with 3 uses per filter, around l70'OOO Sfr. are saved
yearly in our center.
—Autonomous hemodialysis: by treating 69 patients autonomously(26 at home and 43 in different self—care units) out of a total of 122
hemodialysis patients, the cost reduction effectively obtained during
1984 represents SFr. 3'200'000 when compared to all center
hemodialysis.
Conclusions: 1) it does not seem that a return to more restrictive
patient selection criteria can be at present conducted on a medically and
ethically justifiable basis; 2) dialyzer re-use represents only a minor
fraction of the potential cost saving; 3) an integrated program combining
all forms of ESRF therapy and developing autonomous hemodialysis
instead of center hemodialysis appears at present as the most effective
approach.
Blood levels and cardiovascular, endocrine and excretory effects of
atrial natriuretic peptide during different sodium intakes in man.
Weid,nann P, Hellmdller B, Uehlinger DE, Lang RE, Gnddinger tviP,
Shaw S, Medizinische Poliklinik, University of Bern, Switzerland, and
Dept. of Phar,nacology, University of Heidelberg, Federal Republic of
Germany. To evaluate atrial natriuretic peptide (ANP) in humans (h),
we investigated in 10 normal men on sodium (Nat) intakes of 17, 140
and 310 mEqlday plasma ahANP levels and effects of synthetic ahANP
on blood pressure (BP), heart rate (HR), plasma catecholamine, renin
(PRA), aldosterone (PA), cortisol (PC), hematocrit, plasma volume,
and Na and water excretion. Plasma ahANP (by radioimmunoassay)
following five day on low, "normal" or high Na intake averaged 37
5 (± SaM), 54 13 and 46 8 pg/mI. ahANP infused at .1 g/kg/min
produced on all Na intakes a similar fall in diastolic BP(P < 0.001) and
rise in HR (P < 0.00!) and plasma norcpinephrine (P < 0.001) with
unchanged epinephrine and dopamine levels, a reduction in PC and PA
(P < 0.01 to <0.001) despite raised PRA (P < 0.05 to < 0.001) and
unchanged plasma electrolytes, and a plasma volume contraction (P <
0.00!) not explained by renal excretion alone. ahANP-induced diuresis
and natriuresis were greater (P < 0.01) on high than on low Na intake.
Therefore, in normal man different Na intakes may in the equilibrated
phase be accompanied by rather discrete variations in circulating
ahANP, but marked modifications in renal excretory responses to
ahANP. Regardless of Na* intake, ahANP can promote BP reduction
and hemoconcentration by mechanisms other than renal losses, elicit
sympathetic activation, and depress PC and PA despite activated PRA.
Prevention of peritonitis during CAPD by Y-connected double bag
system. WOst J, Binswanger U, Bichsel G, Nephrologische Station,
institut für Mikrobiologie, Universitdt Zurich, Grosse Apotheke
Interlaken, Switzerland. A low rate of peritonitis observed with double
bag systems is thought to be the result of outward flushing of bacteria
entered in the tubing lumen during connection. To test this hypothesis,
dialysate movements were performed in vitro as occurring during
patient treatment. Connection sites were inoculated with coagulase
negative staphylococci amounting to 5 - l0, 5 - l0 and 5 - l0 germs in
a volume of 10 d of boullion. After flushing the inoculation site with 2
liters of dialysate, a new charge of 2 liters was counterpassed and
collected in a dialysate bag. 100cc to I liter out of this bag was filtered
through a milipore filter which was cultured. Colony counts (M; range)
amounted to 50 (0—190); 436 (22—670) and 5484 (160—14140) for
respective inocula. Y-connected double bag sets decrease the number
of contaminating bacteria to about 1% and therefore might contribute to
the prevention of peritonitis during CAPD.
Altered body fat distribution in patients treated with glucocorticoids
and in patients on long—term dialysis. ZOrcher RM, Horber FF, Crivelli
MA, Rohotti G, Frey FJ, Medizinische Poliklinik, Department of
Medicine, Pulmonary Division and institute of Radiology, University of
Berne, inselspital, Berne, Switzerland. The purpose of the present
study was to determine quantitatively fat distribution at different
anatomic localizations by computed tomography in normal volunteers
(N = 42), patients on long—term dialysis (N = 18) and patients treated
with glucocorticoids [renal transplant patients (N = 49), other diseases(N = 17)]. Patients treated with glucocorticoids had higher mean
mediastinal (internal) fat areas (males 4- 200%, females + 400%) than
their corresponding healthy controls. Male patients on hemodialysis or
treated with glucocorticoids exhibited a 30% higher mean buccal or
midthigh fat area, and female transplant patients had a 80% higher
buccal fat area than their corresponding healthy control subjects. The
pattern of body fat distribution in patients on long—term dialysis
mimicked the distribution observed in patients treated with
glucocorticoids. Healthy female subjects had more than 80% higher
ratios of external (buccal and midthigh) to internal (mediastinal) fat than
healthy male subjects. Patients on prednisone and patients on
long—term dialysis lost this sex specific difference in body fat distribu-
tion. Conclusions: Since patients on prednisone exhibit increased or
normal thigh fat depots in the presence of increased mediastinal fat
depots, the current concept that glucocorticoids induce redistribution of
body fat from peripheral to central fat compartments has to be revised.
Furthermore, disease states and/or glucocorticoid treatment abrogates
sex specific differences in body fat distribution.
